Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Abeona Therapeutics
AddedFeb 21, 2024
UpdatedJun 18, 2026
Abeona Therapeutics

Abeona Therapeutics

Public

Abeona Therapeutics, a NYC-based medical organization, develops gene therapies for deadly childhood diseases and manufactures next-gen AAV capsids.

HQ
New York City, NY, US
Founded
1989
Overview
Compare
Fundraising
Employees
Website

Abeona Therapeutics, founded in New York City, focuses on developing gene therapies for severe childhood diseases, including Sanfilippo Syndrome Types A and B. The company leverages its expertise in manufacturing, delivery, development, and discovery of novel gene and cell therapies. Abeona's robust pipeline includes advanced AAV capsids and therapies such as prademagene zamikeracel for RDEB and ABO-50X for genetic eye disorders. Their fully operational manufacturing facility supports both preclinical and clinical studies.

Notable affiliated individuals include scientific advisors and researchers specializing in gene therapy. Abeona has attracted significant investment from biotech-focused venture capital firms. Key achievements include the submission of a Biologics License Application (BLA) for prademagene zamikeracel and advancements in their genetic eye disorder treatments. Abeona's impact is marked by its innovative approach to addressing unmet medical needs in pediatric genetic disorders, positioning it as a leader in the gene therapy space.

Abeona Therapeutics - Similar Companies

Apertura Gene Therapy logo

Apertura Gene Therapy

aperturagtx.com

Agtc logo

Agtc

beacontx.com

Atsena Therapeutics logo

Atsena Therapeutics

atsenatx.com

Akebia Therapeutics logo

Akebia Therapeutics

akebia.com

bluebird bio logo

bluebird bio

bluebirdbio.com

Aavogen logo

Aavogen

aavogen.com

Affinia Therapeutics logo

Affinia Therapeutics

affiniatx.com

Regenxbio logo

Regenxbio

regenxbio.com

Frontera Therapeutics logo

Frontera Therapeutics

Kate Therapeutics logo

Kate Therapeutics

NabGen logo

NabGen

nabgen.com

Capsida Biotherapeutics logo

Capsida Biotherapeutics

capsida.com

Taysha Gene Therapies logo

Taysha Gene Therapies

tayshagtx.com

Locanabio logo

Locanabio

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Abeona Therapeutics - Quick Facts

Who are Abeona Therapeutics' competitors?

Companies similar to Abeona Therapeutics include Apertura Gene Therapy, Agtc, Atsena Therapeutics and Akebia Therapeutics.

When was Abeona Therapeutics founded?

Abeona Therapeutics was founded in 1989.

Where is Abeona Therapeutics' headquarters located?

Abeona Therapeutics' headquarters is located in New York City, NY, US.

When was Abeona Therapeutics' last funding round?

Abeona Therapeutics' most recent funding round was for $20M (USD) in January 2024.

How much has Abeona Therapeutics raised to-date?

As of Jan 8, 2024, Abeona Therapeutics has raised a total of $354.7M (USD).

How many employees does Abeona Therapeutics have?

Abeona Therapeutics has 95 employees as of Feb 6, 2024.

Abeona Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Gene Therapy
Tags
  • Healthtech
Unique IDs
  • ein: 830221517
  • secCik: 0000318306
  • ticker: ABEO
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified